Presentation of galectin-1 by extracellular matrix triggers T cell death

Area of Science:

• Immunology
• Molecular Biology
• Cancer Biology

Background:

• Apoptosis of T cells at inflammation or tumor sites impedes effective immune responses.
• Galectin-1 is a secreted lectin that can induce T cell apoptosis via cell surface or extracellular matrix binding.
• The in vivo function of galectin-1 as a soluble versus cell-associated death trigger remains unclear.

Purpose of the Study:

• To investigate whether galectin-1 secreted by stromal cells can induce T cell apoptosis in vivo.
• To determine the mechanism by which galectin-1 mediates T cell death, focusing on soluble versus cell-associated forms.
• To assess the role of extracellular matrix-bound galectin-1 in T cell elimination.

Main Methods:

• Co-culture of T cells with stromal cells engineered to secrete galectin-1.
• Analysis of galectin-1 localization (cell surface vs. secreted) and T cell apoptosis.
• Culture of stromal cells on Matrigel or permeable membranes to mimic extracellular matrix interactions.
• Comparison of T cell killing by cell-associated, soluble, and matrix-bound galectin-1.

Main Results:

• Stromal cells synthesized galectin-1, which predominantly remained cell-surface bound and induced apoptosis in T cells upon contact.
• Soluble galectin-1 released into the media was insufficient to induce T cell apoptosis.
• When stromal cells were cultured on Matrigel, secreted galectin-1 bound to the matrix and effectively killed T cells without direct cell contact.
• Matrix-bound galectin-1 was significantly more potent in inducing T cell apoptosis than soluble galectin-1.

Conclusions:

• Galectin-1 in the extracellular matrix can directly induce apoptosis in susceptible T cells.
• Stromal cell-associated galectin-1 and extracellular matrix-bound galectin-1 are potent mediators of T cell death.
• Galectin-1 deposited in tumor stroma may locally eliminate infiltrating T cells, potentially suppressing anti-tumor immune responses.